Melanoma Trials in San Antonio, United States
Conditions / Melanoma / San Antonio, United States
Melanoma has been the subject of sustained clinical investigation across multiple research sites.
44 total trials for this combination
Showing top 10 of 44 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02009449 | A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors | COMPLETED | PHASE1 |
| NCT02628535 | Safety Study of MGD009 in B7-H3-expressing Tumors | TERMINATED | PHASE1 |
| NCT06910657 | IDOV-Immune for Advanced Solid Tumors | RECRUITING | PHASE1 |
| NCT03629756 | A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies | COMPLETED | PHASE1 |
| NCT04913337 | Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |
| NCT03195699 | Oral STAT3 Inhibitor, TTI-101, in Patients with Advanced Cancers | COMPLETED | PHASE1 |
| NCT05259696 | Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) | COMPLETED | PHASE1/PHASE2 |
| NCT02465060 | Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT03665285 | A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors | COMPLETED | PHASE1/PHASE2 |
| NCT05864144 | A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |